$0.08
0.00%
Nasdaq, Dec 27, 03:30 pm CET
ISIN
BMG0360L1000
Symbol
CYTO
Sector
Industry

Altamira Therapeutics Ltd Target price 2024 - Analyst rating & recommendation

Altamira Therapeutics Ltd Classifications & Recommendation:

Buy
100%

Altamira Therapeutics Ltd Price Target

Target Price $290.46
Price $0.07
Potential
Number of Estimates 1
1 Analyst has issued a Altamira Therapeutics Ltd price target 2025. The average Altamira Therapeutics Ltd target price is $290.46. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Altamira Therapeutics Ltd to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Altamira Therapeutics Ltd stock has an average upside potential 2025 of . Most analysts recommend the Altamira Therapeutics Ltd stock at Purchase.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today